Cytokines, growth factors and metabolic bone disease;Citoquinas, factores de crecimiento y enfermedad ósea metabólica

Revista Medica de Chile

Volumn 124, Issue 2, 1996, Pages 248-257

  Pumarino C, Hugo ^a   Pumarino B, María Gabriela ^a  

^a NONE

Author keywords

Bone diseases, metabolic; Cytokines; Growth

Indexed keywords

CYTOKINE; GROWTH PROMOTOR;

BONE REMODELING; HUMAN; METABOLIC BONE DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

BONE DISEASES, METABOLIC; BONE REMODELING; CYTOKINES; GROWTH SUBSTANCES; HUMANS;

EID: 0030072627     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. OPPENHEIM JJ, RUSCETTI FW, FALTYNEK C. Cytokines. En: Sites DP, Terr AL. Basic and clinical immunology 7th Edition 1991. Appleton & Lange USA.
2. ABBAS AK, LICHTMAN AH, POBER JS. Citokines (Chapter 12) En: Cellular and molecular immunology. 2th Edition. WB Saunders 1994.
3. AGGARWAL BB, POCSIK E. Cytokines: From clone to clinic. Arch Bioch Biophys 1992; 292: 335-59.
4. WATERFIELD MD. Introduction. Growth factors. Br Med Bull 1989; 45: 317-8.
5. ARAI K, LEE F, MIYAJIMA A, MIYATAKE S, ARAI N, YAKOTA T. Cytkines: Coordinators of immune and inflamatory responses. Ann Rev Biochem 1990; 59: 783-836.
6. BRONCHUD MH, DEXTER TM. Clinical use of growth factors. Br Med Bull 1989; 45: 590-9.
7. GOWEN M. Cytokines and bone metabolism. CRC Pres 1992, Boca Raton FL.
8. CANALIS E, MC CARTHY TL, CENTRELLA M. Growth factors and cytokines in bone cell metabolism Annual Rev Med 1991; 42: 17-24.
9. RAISZ LG. Local and systemic factors in the pathogenesis of osteoporosis. N Engl J Med 1988; 318: 818-828.
10. MANOLOGAS SC, VILLEA RL. Bone Marrow, Cytokines and bone remmodeling. N Engl J Med 1995; 332: 305-11.
11. DE VERNEJOUL MC, COHEN-SOLAL M, ORCEL P. Bone cytokines. Curr Opin Rheumatol 1993; 5: 332-8.
12. MUNDY GR. Cytokines and growth factors in the regulation of bone remodeling. J Bone Miner Res 1993; 8 suppl 2; S 505-10.
13. DINARELLO CA, WOLF SM. The role of interleukin-1 disease. N Engl J Med 1993; 328: 106-113.
14. DEWHIRST FE, STASHENKO PP, MOLE JE ET AL. Purification and partial sequence of human osteoclast activating factor, identy with interleukin-1. J Immunol 1985; 135: 2562-6.
15. GOWEN M, MUNDY GR. Actions of recombinant 1, interleukin 2, and interferon-gamma on bone resorption in vitro. J Immunol 1986; 136: 2478-82.
16. RALSTON SH. Analysis of gene expresion in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 1994; 9: 883-90.
17. PACIFIC R, VANNICE JL, RIFAS L, KIMBLE RB. Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab 1993; 77: 1135-41.
18. RIANCHO JA, ZARRABEITIA MT, AMADO JA, OLMOS JM; GONZALEZ-MACIAS J. Age-related differences in cytokine secretion. Gerontology 1994; 40: 8-12.
19. JILKA RL, HANGOC G, GIRASOLE G ET AL. Increased osteoclast development after estrogen loss: mediated by interleukin-6. Science 1992; 257: 88-91.
20. KHOSLA S, PETERSON JM, EGAN K, JONES JD, RIGGS BL. Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab 1994; 79: 707-711.
21. GIRASOLE G, PASSERI G, JILKA RL, MANOLAGAS SC. Interleukin-11: A new cytokine critical for osteoclast development. J Clin Invest 1994; 93: 1516-24.
22. CENTRELLA M. HOROWITZ MC, WOZNEY JM, MC CARTHY TL. Transforming growth factor β gene family members and bone. Endocrine Rev 1994; 15: 27-39.
23. HATTERSLEY G, CHAMBERS TJ. Effects of tranforming growth factor β 1 on the regulation of osteoclastic development and function. J Bone Miner Res 1991; 6: 165-172.
24. MUNDY GR. Hypercalcemic factors other than Parathyroid hormone-related protein Endocr Metab Clinics North America 1989; 18: 795-806.
25. BAYLINK DJ, FINKELMAN RD, MOHAN S. Growth factors to stimulate bone formation. J Bone Miner Res 1993; Suppl 2: S565-72.
26. WERGEDAL JE, MOHAN S, LUNDY M, BAYLINK DJ. Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. J Bone Miner Res 1990; 5 179-189.
27. CANALIS E, MC CARTHY TL, CENTRELLA M. The role of growth factors in skeletal remodeling. Endocrinol Metab Clin North America 1989; 15: 903-18.
28. THIESEN JP, KETELSLEGERS JM, UNDERWOOD LE. Nutritional regulation of the Insuline-like growth factors. Endocrine Rev 1994; 15: 80-101.
29. REDDI AH, CUNNINGHAN NS. Initiation and promotion of bone differentiation by bone morphogenetic proteins. J Bone Miner Res 1993; 8 (52) S499-502.
30. GALARZA S, PUMARINO H. Miositis osificante progresiva. Aspectos patogénicos y terapéuticos. Rev Méd Chile 1978; 106: 932-6.
31. BAYLINK DJ, PLOTKIN H, ZANCHETTA JR, TALBOT YJR. Factores de crecimiento óseo y osteoporosis. Modelo de acoplamiento. Rev Española Enf Metab Oseas 1994; 1994; 3: 189-190.
32. MANOLAGAS SC. Role of cytokines in bone resorption. Bone 1995; 17 (Suppl): 63S-67S.
33. MAYDEN JM, MOHAN S, BAYLINK DJ. The insuline-like growth factor system and the coupling of formation to reabsorption. Bone 1995; 17 (Suppl 1): 93S-98S.
34. KASSEM M, KHOSLA S, RIGGS BL. No evidence in early post menopausal women for estrogen regulation of cytokine production: assesment in bone marrow plasma in vivo and in cultured bone marrow cells. J Bone Min Res 1995; 10 (Suppl 1): S177 (abstract).
35. RIGGS BL. Experimental therapeutic approachs to disorders of calcium and bone metabolism: IGF-I and other growth factors. Seventeenth Annual Meeting of the American Society for Bone and Mineral Research. Baltimore, Maryland, Sept 9-13, 1995.